Natural Product: NPC319633

Natural Product IDNPC319633
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
UYTAXAWTQDKVBD-SDNWHVSQSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 5312846
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0000262] Fatty acids and conjugates
          • [CHEMONTID:0002949] Long-chain fatty acids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey UYTAXAWTQDKVBD-SDNWHVSQSA-N
Standard InCHI InChI=1S/C18H34O3/c1-2-3-4-5-6-8-11-14-17(19)15-12-9-7-10-13-16-18(20)21/h11,14,17,19H,2-10,12-13,15-16H2,1H3,(H,20,21)/b14-11+
SMILES CCCCCCCC=CC(CCCCCCCC(=O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   298.25 Volume:   340.982
?
Van der Waals volume.
Dense:   0.875 LogP:   5.006
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.186
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.16
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   15.0 Rigid Bonds:   2.0
TPSA:   57.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   2.0 Rings:   0.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.327 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.657 Fsp3:   0.833
MCE-18:   2.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.029 Fluc inhibitor:   0.006
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.015
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.985 Promiscuous compounds:   0.304

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.142 MDCK Permeability:   -4.737
Pgp-inhibitor:   0.0 Pgp-substrate:   0.035
PAMPA:   0.791
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.955
20% Bioavailability (F20%):   0.729 30% Bioavailability (F30%):   0.982
50% Bioavailability (F50%):   0.612

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.05 MRP1:   0.977
Plasma Protein Binding (PPB):   92.735% Volume Distribution (VD):   0.237
Fu: 4.898%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.05
OATP1B3 inhibitor:   0.989 BCRP inhibitor:   0.07
BSEP inhibitor:   0.092

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.538
CYP2C19-inhibitor:   0.005 CYP2C19-substrate:   0.047
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.012
CYP2D6-inhibitor:   0.926 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.995
CYP2B6-substrate:   0.993 CYP2C8-inhibitor:   0.99
HLM stability:   0.007
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.643 Half-life (T1/2):  0.832

ADMET: Toxicity

hERG Blockers:  0.124 hERG Blockers (10um):  0.311
Human Hepatotoxicity (H-HT):  0.351 Drug-induced Liver Injury (DILI):  0.022
AMES Toxicity:  0.101 Rat Oral Acute Toxicity:  0.063
Maximum Recommended Daily Dose:  0.17 Skin Sensitization:  0.986
Carcinogencity:  0.116 Eye Corrosion:  0.886
Eye Irritation:  0.994 Respiratory Toxicity:  0.849
Drug-induced Neurotoxicity:  0.022 Ototoxicity:  0.699
Hematotoxicity:  0.098 Drug-induced Nephrotoxicity:  0.337
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.028
A549 Cytotoxicity:  0.076 Hek293 Cytotoxicity:  0.041
BCF:   1.107
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.042
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.388
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   2.665
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12126 Coix lacryma-jobi Species Poaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO12126 Coix lacryma-jobi Species Poaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO12126 Coix lacryma-jobi Species Poaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO12126 Coix lacryma-jobi Species Poaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO12126 Coix lacryma-jobi Species Poaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC319633 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8462 Intermediate Similarity NPC255863
0.8462 Intermediate Similarity NPC136164
0.8462 Intermediate Similarity NPC245947
0.7143 Intermediate Similarity NPC243532
0.7143 Intermediate Similarity NPC99619
0.7 Intermediate Similarity NPC606120
0.6944 Remote Similarity NPC424
0.6944 Remote Similarity NPC36061
0.6944 Remote Similarity NPC69510
0.6944 Remote Similarity NPC77272
0.6944 Remote Similarity NPC290563
0.6944 Remote Similarity NPC139029
0.6944 Remote Similarity NPC281972
0.6944 Remote Similarity NPC261831
0.6944 Remote Similarity NPC87564
0.6818 Remote Similarity NPC470320
0.6757 Remote Similarity NPC95145
0.6757 Remote Similarity NPC325642
0.6757 Remote Similarity NPC65174
0.6667 Remote Similarity NPC323045
0.6667 Remote Similarity NPC49863
0.6667 Remote Similarity NPC317881
0.6667 Remote Similarity NPC281245
0.6579 Remote Similarity NPC324004
0.6579 Remote Similarity NPC328497
0.6486 Remote Similarity NPC92114
0.6444 Remote Similarity NPC327112
0.641 Remote Similarity NPC154245
0.641 Remote Similarity NPC85813
0.641 Remote Similarity NPC223697
0.641 Remote Similarity NPC6095
0.6304 Remote Similarity NPC26500
0.6222 Remote Similarity NPC325627
0.6154 Remote Similarity NPC321062
0.6 Remote Similarity NPC88735
0.587 Remote Similarity NPC323477
0.5769 Remote Similarity NPC192006
0.5769 Remote Similarity NPC227396
0.575 Remote Similarity NPC5413
0.5714 Remote Similarity NPC171736
0.5714 Remote Similarity NPC301585
0.5714 Remote Similarity NPC261080
0.5714 Remote Similarity NPC132565
0.5714 Remote Similarity NPC209970
0.5714 Remote Similarity NPC216630
0.5714 Remote Similarity NPC201844
0.5714 Remote Similarity NPC301696
0.5714 Remote Similarity NPC196924
0.5714 Remote Similarity NPC307783
0.5714 Remote Similarity NPC154186
0.5714 Remote Similarity NPC149184
0.5714 Remote Similarity NPC279026
0.5714 Remote Similarity NPC113928
0.5714 Remote Similarity NPC14227
0.5714 Remote Similarity NPC605544
0.5714 Remote Similarity NPC607260
0.566 Remote Similarity NPC7414
0.566 Remote Similarity NPC279537
0.566 Remote Similarity NPC47031
0.561 Remote Similarity NPC52955
0.561 Remote Similarity NPC88966
0.561 Remote Similarity NPC25417
0.561 Remote Similarity NPC1813
0.561 Remote Similarity NPC59051
0.5556 Remote Similarity NPC106851
0.5556 Remote Similarity NPC282788
0.5556 Remote Similarity NPC274927
0.5556 Remote Similarity NPC477201
0.5532 Remote Similarity NPC318420
0.5532 Remote Similarity NPC326268
0.5455 Remote Similarity NPC225929
0.5435 Remote Similarity NPC179764
0.5429 Remote Similarity NPC155263
0.54 Remote Similarity NPC328653
0.5366 Remote Similarity NPC91495
0.5366 Remote Similarity NPC70387
0.5319 Remote Similarity NPC251042
0.5319 Remote Similarity NPC174447
0.5319 Remote Similarity NPC122521
0.5306 Remote Similarity NPC470965
0.5283 Remote Similarity NPC260814
0.5283 Remote Similarity NPC323249
0.5283 Remote Similarity NPC27949
0.5283 Remote Similarity NPC39547
0.5263 Remote Similarity NPC180534
0.5263 Remote Similarity NPC611531
0.5238 Remote Similarity NPC472808
0.5208 Remote Similarity NPC68343
0.5208 Remote Similarity NPC321838
0.5208 Remote Similarity NPC328089
0.5128 Remote Similarity NPC200618
0.5128 Remote Similarity NPC131770
0.5128 Remote Similarity NPC90904
0.5111 Remote Similarity NPC487561
0.5106 Remote Similarity NPC324475
0.5091 Remote Similarity NPC319163
0.5091 Remote Similarity NPC67076

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC319633 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6944 Remote Similarity NPD3195 Phase 2
0.6944 Remote Similarity NPD3196 Approved
0.6667 Remote Similarity NPD4247 Clinical (unspecified phase)
0.6585 Remote Similarity NPD3194 Phase 4
0.6444 Remote Similarity NPD4246 Phase 2
0.641 Remote Similarity NPD4266 Phase 2
0.575 Remote Similarity NPD3173 Phase 4
0.5714 Remote Similarity NPD2270 Pre-clinical
0.5714 Remote Similarity NPD633 Phase 3
0.5714 Remote Similarity NPD9448 Phase 2
0.566 Remote Similarity NPD4269 Phase 4
0.566 Remote Similarity NPD4270 Approved
0.561 Remote Similarity NPD3172 Approved
0.5283 Remote Similarity NPD4271 Phase 4
0.5263 Remote Similarity NPD622 Pre-clinical
0.5208 Remote Similarity NPD39 Phase 4
0.5106 Remote Similarity NPD3198 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data